Acurx Pharmaceuticals, Inc. (ACXP)

CIK 1736243 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acurx Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Oct 29, 20268-K0001104659-26-120279
Oct 16, 20268-K0001104659-26-116632
Sep 17, 2026EFFECT9999999995-26-003000
Sep 17, 2026424B30001104659-26-108599
Sep 8, 2026S-10001104659-26-105917
Sep 1, 2026ARS0001104659-26-104320
Sep 1, 2026DEFA14A0001104659-26-104319
Sep 1, 2026DEF 14A0001104659-26-104316
Aug 13, 202610-Q0001104659-26-095904
May 12, 2026424B30001104659-26-059298
May 12, 2026424B30001104659-26-059296
May 11, 202610-Q0001104659-26-058631
May 11, 2026EFFECT9999999995-26-001577
May 11, 2026EFFECT9999999995-26-001578
May 4, 2026S-10001104659-26-054884
May 4, 2026S-10001104659-26-054887
Apr 29, 2026D0001736243-26-000001
Apr 22, 202640001104659-26-046835
Apr 22, 202640001104659-26-046837
Apr 22, 202640001104659-26-046846
Apr 22, 202640001104659-26-046844
Apr 22, 202640001104659-26-046842
Apr 22, 202640001104659-26-046833
Apr 22, 202640001104659-26-046840
Apr 22, 202640001104659-26-046836